| Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy (NCT04447118) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-11 |
| The PK/PD Study of SHR7280 Tablets in Healthy Subjects. (NCT04554043) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-11 |
| A Safety and Efficacy Study of SHR-1702 Monotherapy in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) (NCT04443751) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-10 |
| Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects (NCT05088343) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-07 |
| A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors (NCT04446260) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-07 |
| A Trial of Hetrombopag in Healthy Subjects (NCT05088174) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-03 |
| A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia (NCT04455581) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-01 |
| The Single, Multiple Dose and Food Effect Study of SHR2285 Tablets on Pharmacokinetics and Pharmacodynamics in Healthy Subjects (NCT04472819) | Jiangsu HengRui Medicine Co., Ltd. | 2020-08-28 |
| A Multiple Dose Study to Evaluate the Effect of SHR-1222 Injection in Postmenopausal Osteoporosis Patients (NCT04435158) | Jiangsu HengRui Medicine Co., Ltd. | 2020-08-25 |
| A Bioequivalence Study to Compare Two Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects (NCT04527484) | Jiangsu HengRui Medicine Co., Ltd. | 2020-08-20 |
| A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy (NCT04300114) | Jiangsu HengRui Medicine Co., Ltd. | 2020-08-19 |
| The Multiple Dose of PK/PD Study of SHR2285 Tablets in Healthy Subjects (NCT04229433) | Jiangsu HengRui Medicine Co., Ltd. | 2020-08-11 |
| A Trial of Famitinib in Patients With Failure of First-Line Treatment For Intrahepatic Cholangiocarcinoma (NCT04479904) | Jiangsu HengRui Medicine Co., Ltd. | 2020-08-10 |
| Pharmacokinetics, Pharmacodynamics and Safety of SHR4640 in Patients With Hepatic Impairment (NCT04305392) | Jiangsu HengRui Medicine Co., Ltd. | 2020-08-04 |
| A Trial of SHR-1703 in Healthy Adults (NCT04480762) | Jiangsu HengRui Medicine Co., Ltd. | 2020-08-04 |
| A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis (NCT04333771) | Jiangsu HengRui Medicine Co., Ltd. | 2020-07-31 |
| The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis. (NCT04417972) | Jiangsu HengRui Medicine Co., Ltd. | 2020-07-30 |
| A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Oral HRS5091 in Healthy Subjects and Chronic Hepatitis B Patients (NCT04480294) | Jiangsu HengRui Medicine Co., Ltd. | 2020-07-28 |
| A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects. (NCT04428086) | Jiangsu HengRui Medicine Co., Ltd. | 2020-07-27 |
| A Drug-drug Interaction Trial to Evaluate the Pharmacokinetics Effect of Rifampicin on Famitinib (NCT04494659) | Jiangsu HengRui Medicine Co., Ltd. | 2020-07-20 |
| Safety, Tolerability, Pharmacokinetics(PK), Pharmacodynamics(PD) and Food Effect of HRS9950 in Healthy and CHB Subjects (NCT04464733) | Jiangsu HengRui Medicine Co., Ltd. | 2020-07-20 |
| Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (NCT04342936) | Jiangsu HengRui Medicine Co., Ltd. | 2020-07-17 |
| A Phase I Study of SHR1459 in Healthy Subjects (NCT04455100) | Jiangsu HengRui Medicine Co., Ltd. | 2020-07-17 |
| A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC (NCT04316364) | Jiangsu HengRui Medicine Co., Ltd. | 2020-07-14 |
| A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer. (NCT04335006) | Jiangsu HengRui Medicine Co., Ltd. | 2020-07-14 |
| A Study of Fluzoparib±Apatinib Versus Chemotherapy Treatment of Physician's Choice in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation (NCT04296370) | Jiangsu HengRui Medicine Co., Ltd. | 2020-07-13 |
| Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer (NCT04426955) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-30 |
| A Bioavailability Study of SHR1459 on Healthy Chinese Volunteers (NCT04395053) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-28 |
| Effect of Rifampicin on the Pharmacokinetics of SHR6390 in Healthy Subjects (NCT04439578) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-23 |
| A Trial of SHR-1802 in Patients With Failure of Standard Treatment for Advanced Malignant Tumours (NCT04414150) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-17 |
| Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC) (NCT04203485) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-15 |
| The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole (NCT04676035) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-15 |
| A Clinical Study of Remimazolam Tosilate in Patients Undergoing Bronchoscopy (NCT04400201) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-15 |
| A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer (NCT04400188) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-11 |
| Effect of Itraconazole on the Pharmacokinetics of SHR6390 in Healthy Subjects (NCT04423601) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-10 |
| A Study to Evaluate the Pharmacokinetics of Apatinib in Subjects With Impaired Renal Function (NCT04414852) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-05 |
| Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor (NCT04346381) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-05 |
| A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy (NCT04229615) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-02 |
| A Itraconazole Effect Study of SHR2554 on Healthy Chinese Adult Subjects (NCT04627129) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-01 |
| Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion (NCT04664725) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-01 |
| A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Adults (NCT04383418) | Jiangsu HengRui Medicine Co., Ltd. | 2020-05-31 |
| Pharmacokinetic Study of Pyrotinib and Docetaxel in Combination With Trastuzumab in Patients With HER2 Metastatic Breast Cancer (NCT04367090) | Jiangsu HengRui Medicine Co., Ltd. | 2020-05-28 |
| A Rifampin Effect Study of SHR2554 on Healthy Chinese Adult Subjects (NCT04577885) | Jiangsu HengRui Medicine Co., Ltd. | 2020-05-28 |
| A Bioequivalence Study of Famitinib Malate on Healthy Chinese Volunteers (NCT04400123) | Jiangsu HengRui Medicine Co., Ltd. | 2020-05-27 |
| Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients (NCT04390984) | Jiangsu HengRui Medicine Co., Ltd. | 2020-05-26 |
| A Food Effect Study of SHR1459 on Healthy Chinese Adult Subjects (NCT04291846) | Jiangsu HengRui Medicine Co., Ltd. | 2020-05-24 |
| Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment (NCT04293029) | Jiangsu HengRui Medicine Co., Ltd. | 2020-05-20 |
| A Study of SHR0410 in Hemodialysis Patients With Pruritus (NCT04317209) | Jiangsu HengRui Medicine Co., Ltd. | 2020-05-17 |
| A Food Effect Study of Apatinib Mesylate in Healthy Subjects (NCT04341090) | Jiangsu HengRui Medicine Co., Ltd. | 2020-05-13 |
| A Food Effect Study of FMTN on Healthy Chinese Adult Subjects (NCT04616716) | Jiangsu HengRui Medicine Co., Ltd. | 2020-05-06 |
| Apatinib and Etoposide Capsule Versus Apatinib in Patients With Platinum Resistant Ovarian Cancer (NCT04383977) | Jiangsu HengRui Medicine Co., Ltd. | 2020-05-01 |
| A Drug-drug Interaction Trial of Loperamide Pharmacokinetics Effect on Pyrotinib Maleate (NCT04315116) | Jiangsu HengRui Medicine Co., Ltd. | 2020-04-13 |
| Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese Subjects (NCT04341077) | Jiangsu HengRui Medicine Co., Ltd. | 2020-04-10 |
| A Study to Compare Pharmacokinetic and Safety Profiles of Different Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects (NCT04326881) | Jiangsu HengRui Medicine Co., Ltd. | 2020-04-07 |
| SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT04282070) | Jiangsu HengRui Medicine Co., Ltd. | 2020-03-27 |
| Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR4640 in Chinese Healthy Adult Male Volunteers. (NCT04260373) | Jiangsu HengRui Medicine Co., Ltd. | 2020-03-19 |
| A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Transporter Pgp Substrate Digoxin in Advanced Solid Tumor Subjects (NCT04322552) | Jiangsu HengRui Medicine Co., Ltd. | 2020-03-12 |
| Effect of Low-fat Diet on the Pharmacokinetics of Pyrotinib in Healthy Participants (NCT04315493) | Jiangsu HengRui Medicine Co., Ltd. | 2020-03-01 |
| A Study of SHR-1501 Combined With SHR-1316 in Patients With Advanced Tumors (NCT03995472) | Jiangsu HengRui Medicine Co., Ltd. | 2020-02-14 |
| A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer (NCT04228601) | Jiangsu HengRui Medicine Co., Ltd. | 2020-01-21 |
| A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children (NCT04200235) | Jiangsu HengRui Medicine Co., Ltd. | 2020-01-06 |
| Food Effect Study of DDO-3055 Tablets in Healthy Subjects (NCT04197778) | Jiangsu HengRui Medicine Co., Ltd. | 2020-01-06 |
| A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia (NCT04180982) | Jiangsu HengRui Medicine Co., Ltd. | 2019-12-03 |
| A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults (NCT04121143) | Jiangsu HengRui Medicine Co., Ltd. | 2019-11-09 |
| Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy. (NCT03976882) | Jiangsu HengRui Medicine Co., Ltd. | 2019-11-06 |
| A Study of SHR-1501 in Patients With Advanced Tumors (NCT04025957) | Jiangsu HengRui Medicine Co., Ltd. | 2019-10-30 |
| A Study of HR071603(Ketamine Nasal Spray) in Healthy Subjects (NCT04108234) | Jiangsu HengRui Medicine Co., Ltd. | 2019-10-24 |
| The Drug-Drug Interaction of SHR4640 and Febuxostat in Patients With Hyperuricemia (NCT04157959) | Jiangsu HengRui Medicine Co., Ltd. | 2019-10-14 |
| A Study of Abiraterone in Combination With SHR3162 in the Treatment of mCRPC (NCT04108247) | Jiangsu HengRui Medicine Co., Ltd. | 2019-09-26 |
| Extension Study of Hetrombopag in Severe Aplastic Anemia (NCT04961710) | Jiangsu HengRui Medicine Co., Ltd. | 2019-09-19 |
| Effect of Itraconazole on the Pharmacokinetics of Pyrotinib in Healthy Subjects (NCT04479891) | Jiangsu HengRui Medicine Co., Ltd. | 2019-09-18 |
| A Study of SHR-1316 and Fluzoparib（SHR-3162） in Small Cell Lung Cancer Patients (NCT04041011) | Jiangsu HengRui Medicine Co., Ltd. | 2019-09-17 |
| Effect of Omeprazole on PK of Fluzoparib in Healthy Male Subjects (NCT04108676) | Jiangsu HengRui Medicine Co., Ltd. | 2019-09-07 |
| Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide (NCT06083116) | Jiangsu HengRui Medicine Co., Ltd. | 2019-08-28 |
| Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer (NCT04000295) | Jiangsu HengRui Medicine Co., Ltd. | 2019-08-16 |
| A Food Effect Study of SHR2554 on Healthy Chinese Male Adult Subjects (NCT04335266) | Jiangsu HengRui Medicine Co., Ltd. | 2019-08-06 |
| Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension (NCT03971929) | Jiangsu HengRui Medicine Co., Ltd. | 2019-07-31 |
| A Study of SHR4010 in Patients With Hemodialysis (NCT04099927) | Jiangsu HengRui Medicine Co., Ltd. | 2019-07-28 |
| A Drug-drug Interaction Trial of Rifampicin Pharmacokinetics Effect on Fluzoparib (NCT04011124) | Jiangsu HengRui Medicine Co., Ltd. | 2019-07-24 |
| Effect of Fluconazole on PK of Fluzoparib in Healthy Male Subjects (NCT04193319) | Jiangsu HengRui Medicine Co., Ltd. | 2019-07-19 |
| A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer (NCT03966898) | Jiangsu HengRui Medicine Co., Ltd. | 2019-07-19 |
| A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease (NCT03976115) | Jiangsu HengRui Medicine Co., Ltd. | 2019-07-18 |
| A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout (NCT04052932) | Jiangsu HengRui Medicine Co., Ltd. | 2019-07-16 |
| A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer (NCT03980054) | Jiangsu HengRui Medicine Co., Ltd. | 2019-07-12 |
| Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung Cancer (NCT03777124) | Jiangsu HengRui Medicine Co., Ltd. | 2019-07-11 |
| Study to Evaluate the Mass Balance and Biotransformation of [14C]-Fluzoparib in Chinese Patients With Solid Tumor (NCT04013048) | Jiangsu HengRui Medicine Co., Ltd. | 2019-07-08 |
| The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperlipidemia (NCT03944109) | Jiangsu HengRui Medicine Co., Ltd. | 2019-06-20 |
| A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer (NCT03927456) | Jiangsu HengRui Medicine Co., Ltd. | 2019-06-13 |
| A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC (NCT03764293) | Jiangsu HengRui Medicine Co., Ltd. | 2019-06-10 |
| A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC (NCT03945604) | Jiangsu HengRui Medicine Co., Ltd. | 2019-06-04 |
| A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment. (NCT03605706) | Jiangsu HengRui Medicine Co., Ltd. | 2019-05-31 |
| Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human Subjects (NCT03977805) | Jiangsu HengRui Medicine Co., Ltd. | 2019-05-25 |
| A Clinical Study of Remimazolam Tosilate Compared to Propofol for General Anesthesia During Elective Surgery (NCT03921775) | Jiangsu HengRui Medicine Co., Ltd. | 2019-05-13 |
| Bioequivalence of Fluzoparib(SHR3162) Study on Healthy Chinese Adult Subjects (NCT04521192) | Jiangsu HengRui Medicine Co., Ltd. | 2019-05-06 |
| A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients (NCT03863860) | Jiangsu HengRui Medicine Co., Ltd. | 2019-04-30 |
| A Study of SHR-1702 Alone or With Camrelizumab in Participants With Advanced Relapsed/Refractory Solid Tumors (NCT03871855) | Jiangsu HengRui Medicine Co., Ltd. | 2019-04-28 |
| A Study of Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLC (NCT03904823) | Jiangsu HengRui Medicine Co., Ltd. | 2019-04-25 |
| A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer (NCT03863223) | Jiangsu HengRui Medicine Co., Ltd. | 2019-04-22 |
| The PK/PD Study of A Single Subcutaneous Injection of SHR-1222 in Healthy Subjects (NCT03870100) | Jiangsu HengRui Medicine Co., Ltd. | 2019-04-15 |
| A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC (NCT04102124) | Jiangsu HengRui Medicine Co., Ltd. | 2019-04-08 |